276 related articles for article (PubMed ID: 21551507)
1. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiss A; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2011 Jul; 70(7):1257-63. PubMed ID: 21551507
[TBL] [Abstract][Full Text] [Related]
2. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.
Song IH; Hermann K; Haibel H; Althoff CE; Listing J; Burmester G; Krause A; Bohl-Bühler M; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2011 Apr; 70(4):590-6. PubMed ID: 21372193
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Freundlich B; Lange E; Rudwaleit M; Sieper J
Semin Arthritis Rheum; 2016 Feb; 45(4):404-10. PubMed ID: 26519007
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
[TBL] [Abstract][Full Text] [Related]
5. Erosions and fatty lesions of sacroiliac joints in patients with axial spondyloarthritis: evaluation of different MRI techniques and two scoring methods.
Krohn M; Braum LS; Sieper J; Song IH; Weiss A; Callhoff J; Althoff CE; Hamm B; Hermann KG
J Rheumatol; 2014 Mar; 41(3):473-80. PubMed ID: 24488424
[TBL] [Abstract][Full Text] [Related]
6. Effects of Anti-Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof-of-Concept Study Using Positron Emission Tomography/Magnetic Resonance Imaging of the Sacroiliac Joints and Spine.
Bruckmann NM; Rischpler C; Tsiami S; Kirchner J; Abrar DB; Bartel T; Theysohn J; Umutlu L; Herrmann K; Fendler WP; Buchbender C; Antoch G; Sawicki LM; Tsobanelis A; Braun J; Baraliakos X
Arthritis Rheumatol; 2022 Sep; 74(9):1497-1505. PubMed ID: 35474641
[TBL] [Abstract][Full Text] [Related]
7. Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Lange E; Freundlich B; Rudwaleit M; Sieper J
Rheumatology (Oxford); 2015 Feb; 54(2):257-61. PubMed ID: 25140041
[TBL] [Abstract][Full Text] [Related]
8. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Course of Active Inflammatory and Fatty Lesions in Patients With Early Axial Spondyloarthritis Treated With Infliximab Plus Naproxen as Compared to Naproxen Alone: Results From the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial.
Poddubnyy D; Listing J; Sieper J
Arthritis Rheumatol; 2016 Aug; 68(8):1899-903. PubMed ID: 27015283
[TBL] [Abstract][Full Text] [Related]
10. Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?
de Hooge M; van den Berg R; Navarro-Compán V; Reijnierse M; van Gaalen F; Fagerli K; Landewé R; van Oosterhout M; Ramonda R; Huizinga T; van der Heijde D
Ann Rheum Dis; 2016 Jul; 75(7):1308-14. PubMed ID: 26286018
[TBL] [Abstract][Full Text] [Related]
11. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
12. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
Pedersen SJ; Wichuk S; Chiowchanwisawakit P; Lambert RG; Maksymowych WP
Arthritis Res Ther; 2014 Apr; 16(2):R100. PubMed ID: 24755322
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging of Lesions in the Sacroiliac Joints for Differentiation of Patients With Axial Spondyloarthritis From Control Subjects With or Without Pelvic or Buttock Pain: A Prospective, Cross-Sectional Study of 204 Participants.
Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Hendricks O; Jørgensen NR; Pedersen SJ
Arthritis Rheumatol; 2019 Dec; 71(12):2034-2046. PubMed ID: 31309740
[TBL] [Abstract][Full Text] [Related]
15. Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.
Song IH; Althoff CE; Haibel H; Hermann KG; Poddubnyy D; Listing J; Weiß A; Djacenko S; Burmester GR; Bohl-Bühler M; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2012 Jul; 71(7):1212-5. PubMed ID: 22440819
[TBL] [Abstract][Full Text] [Related]
16. Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.
Rios Rodriguez V; Hermann KG; Weiß A; Listing J; Haibel H; Althoff C; Proft F; Behmer O; Sieper J; Poddubnyy D
Arthritis Rheumatol; 2019 May; 71(5):722-728. PubMed ID: 30625261
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
[TBL] [Abstract][Full Text] [Related]
18. 5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort.
Madari Q; Sepriano A; Ramiro S; Molto A; Claudepierre P; Wendling D; Dougados M; van der Heijde D; van Gaalen FA
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32396521
[TBL] [Abstract][Full Text] [Related]
19. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Lambert RG; Rathmann SS; Pangan AL
Arthritis Rheumatol; 2014 Mar; 66(3):667-73. PubMed ID: 24574227
[TBL] [Abstract][Full Text] [Related]
20. Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Buß B; Freundlich B; Lange E; Alten R; Rudwaleit M; Sieper J
J Rheumatol; 2014 Oct; 41(10):2034-40. PubMed ID: 25028375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
